HLNL logo

Haleon BATS-CHIXE:HLNL Stock Report

Last Price

UK£3.97

Market Cap

UK£36.0b

7D

-3.3%

1Y

20.7%

Updated

10 Mar, 2025

Data

Company Financials +

HLNL Stock Overview

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. More details

HLNL fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance5/6
Financial Health2/6
Dividends2/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Haleon plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Haleon
Historical stock prices
Current Share PriceUK£3.97
52 Week HighUK£4.18
52 Week LowUK£3.11
Beta0.23
1 Month Change4.59%
3 Month Change6.47%
1 Year Change20.68%
3 Year Changen/a
5 Year Changen/a
Change since IPO31.77%

Recent News & Updates

Recent updates

Shareholder Returns

HLNLGB PharmaceuticalsGB Market
7D-3.3%0.3%-2.7%
1Y20.7%8.9%8.8%

Return vs Industry: HLNL exceeded the UK Pharmaceuticals industry which returned 10% over the past year.

Return vs Market: HLNL exceeded the UK Market which returned 9.6% over the past year.

Price Volatility

Is HLNL's price volatile compared to industry and market?
HLNL volatility
HLNL Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement8.1%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.2%
10% least volatile stocks in GB Market2.7%

Stable Share Price: HLNL has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: HLNL's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
171525,408Brian McNamarawww.haleon.com

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.

Haleon plc Fundamentals Summary

How do Haleon's earnings and revenue compare to its market cap?
HLNL fundamental statistics
Market capUK£36.02b
Earnings (TTM)UK£1.44b
Revenue (TTM)UK£11.23b

25.0x

P/E Ratio

3.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HLNL income statement (TTM)
RevenueUK£11.23b
Cost of RevenueUK£4.29b
Gross ProfitUK£6.95b
Other ExpensesUK£5.51b
EarningsUK£1.44b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Jul 31, 2025

Earnings per share (EPS)0.16
Gross Margin61.85%
Net Profit Margin12.84%
Debt/Equity Ratio63.4%

How did HLNL perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

42%

Payout Ratio

Does HLNL pay a reliable dividends?

See HLNL dividend history and benchmarks
When do you need to buy HLNL by to receive an upcoming dividend?
Haleon dividend dates
Ex Dividend DateApr 24 2025
Dividend Pay DateJun 05 2025
Days until Ex dividend44 days
Days until Dividend pay date86 days

Does HLNL pay a reliable dividends?

See HLNL dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/10 03:00
End of Day Share Price 2025/03/10 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Haleon plc is covered by 26 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Iain SimpsonBarclays
Warren AckermanBarclays
Bethan DaviesBerenberg